Clinical
Trials
Finder
Conditions
Drugs
Locations
Institutions
Guides
Search Trials
Get Alerts
Search
Conditions
Drugs
Locations
Institutions
Guides
Search Trials
Get Alerts
Conditions
Transformed Indolent B-Cell Non-Hodgkin Lymphoma to Diffuse Large B-Cell Lymphoma
Chicago, Illinois
Transformed Indolent B-Cell Non-Hodgkin Lymphoma to Diffuse Large B-Cell Lymphoma Clinical Trials in Chicago, Illinois
1 recruiting
Chicago, Illinois
Showing
1–1
of
1
trials
Recruiting
Phase 1
Testing the Combination of Anti-cancer Drugs Mosunetuzumab, Polatuzumab Vedotin, and Lenalidomide for the Treatment of Relapsed/Refractory Diffuse Large B-Cell Lymphoma
High-grade B-cell Lymphoma
Diffuse Large B-Cell Lymphoma, Not Otherwise Specified
Transformed Indolent B-Cell Non-Hodgkin Lymphoma to Diffuse Large B-Cell Lymphoma
National Cancer Institute (NCI)
30 enrolled
8 locations
NCT06015880
Feedback